These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29787819)

  • 1. Budding and tumor-infiltrating lymphocytes - combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups.
    Lang-Schwarz C; Melcher B; Haumaier F; Lang-Schwarz K; Rupprecht T; Vieth M; Sterlacci W
    Hum Pathol; 2018 Sep; 79():160-167. PubMed ID: 29787819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    Iseki Y; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    PLoS One; 2018; 13(4):e0192744. PubMed ID: 29698402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budding, tumor-infiltrating lymphocytes, gland formation: scoring leads to new prognostic groups in World Health Organization low-grade colorectal cancer with impact on survival.
    Lang-Schwarz C; Melcher B; Haumaier F; Schneider-Fuchs A; Lang-Schwarz K; Krugmann J; Vieth M; Sterlacci W
    Hum Pathol; 2019 Jul; 89():81-89. PubMed ID: 31054898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    In Vivo; 2018; 32(1):151-158. PubMed ID: 29275313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma: A Study of 1034 Patients.
    Fuchs TL; Sioson L; Sheen A; Jafari-Nejad K; Renaud CJ; Andrici J; Ahadi M; Chou A; Gill AJ
    Am J Surg Pathol; 2020 Apr; 44(4):536-544. PubMed ID: 31743129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed death ligand 1 (PD-L1) in colon cancer and its interaction with budding and tumor-infiltrating lymphocytes (TILs) as tumor-host antagonists.
    Lang-Schwarz C; Melcher B; Hartmann A; Bertz S; Dregelies T; Lang-Schwarz K; Vieth M; Sterlacci W
    Int J Colorectal Dis; 2021 Nov; 36(11):2497-2510. PubMed ID: 34170390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
    van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
    Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy in stage II and III colon cancer: the role of the "budding and TILs-(tumor-infiltrating lymphocytes) combination" as tumor-host antagonists.
    Lang-Schwarz C; Melcher B; Dregelies T; Norouzzadeh Z; Rund-K├╝ffner S; Lang-Schwarz K; Vieth M; Sterlacci W
    Int J Colorectal Dis; 2021 Aug; 36(8):1765-1779. PubMed ID: 33745027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of Her2-low in colorectal cancer and its relations with the tumor microenvironment.
    Lang-Schwarz C; Vieth M; Dregelies T; Sterlacci W
    Pathol Res Pract; 2023 Apr; 244():154417. PubMed ID: 36947983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
    Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
    World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Infiltrating T Lymphocytes and Apoptosis in Colorectal Cancer.
    Youssef MM; Paish EC; Murray JC; Farag NM; Saleh K; Ellis IO
    Egypt J Immunol; 2015; 22(1):19-28. PubMed ID: 26415369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent Comparison of the Prognostic Values of Tumor Budding, Tumor Stroma Ratio, Tumor Infiltrating Pattern and Lymphocyte-to-Monocyte Ratio in Colorectal Cancer Patients.
    Zhang Y; Liu Y; Qiu X; Yan B
    Technol Cancer Res Treat; 2021; 20():15330338211045826. PubMed ID: 34658263
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical Expression of Immune Checkpoints; CTLA-4, LAG3, and TIM-3 in Cancer Cells and Tumor-infiltrating Lymphocytes (TILs) in Colorectal Carcinoma.
    Abdelrahman DI; Elhasadi I; Anbaig A; Bakry A; Mandour D; Wasefy T; Yehia AM; Alorini M; Shalaby AM; Yahia AIO; Alabiad MA
    Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):71-83. PubMed ID: 38108390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
    Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
    Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Front Immunol; 2018; 9():2354. PubMed ID: 30369930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.